Key result
Visceral fat obesity is linked to ~42% higher estimated 10-year CVD risk versus subcutaneous fat obesity.
Why the study?
Middle-aged women experience weight gain as visceral fat due to menopause-related hormonal changes, and the cardiometabolic risks and influencing factors of visceral fat obesity in this group are not well characterized.
Does Visceral Fat Obesity increase cardiometabolic risk compared to Subcutaneous Fat Obesity in overweight or obese middle-aged Korean women?
Cross-Sectional (n=89)
Yes
Does Visceral Fat Obesity increase cardiometabolic risk compared to Subcutaneous Fat Obesity in overweight or obese middle-aged Korean women?
Visceral fat obesity in middle-aged women is associated with significantly higher cardiometabolic risk than subcutaneous fat obesity, highlighting the importance of targeted lifestyle interventions such as vigorous physical activity.
Visceral fat may confer higher cardiometabolic risk than subcutaneous fat in middle-aged women; hypothesis-generating and should not yet change practice.
Purpose: Middle-aged women often experience weight gain, particularly as visceral fat, due to hormonal changes associated with menopause.Visceral fat, which accumulates in the abdomen, poses significant risks to cardiometabolic health.This cross-sectional study aimed to compare the cardiometabolic risks associated with Visceral Fat Obesity (VFO) and Subcutaneous Fat Obesity (SFO) in middle-aged Korean women and to identify factors that influence VFO.Methods: Women aged 40 to 64 with overweight or obesity were recruited from March to April 2019.The study involved anthropometric measurements, fasting blood tests, and low-volume abdominal computed tomography.Additionally, participants provided self-reported sociodemographic, health-related, and lifestyle information, including Physical Activity (PA) and dietary intake.Results: Of all participants, 70.8% were post-menopausal, and 55.1% had VFO.Those with VFO exhibited significantly higher mean values for waist circumference, total cholesterol, low-density lipoprotein cholesterol, triglycerides, fasting glucose, high sensitivity C-reactive protein, and the Framingham risk score compared to those with SFO.The factors influencing VFO were age (odds ratio (OR)=1.14;95% confidence interval (CI), 1.032~1.247),body mass index (OR=1.47;95% CI, 1.151 ~1.875), days of vigorous PA per week (OR=0.42;95% CI, 0.244~0.735),and intake of animal calcium (OR=0.99;95% CI, 0.988~0.997).Conclusion: The findings indicate that middle-aged women with VFO face increased cardiometabolic risks.Since menopause is inevitable in women, targeting modifiable behaviors to reduce weight, particularly visceral fat, is crucial for lowering cardiometabolic risk.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2024) conducted a cross-sectional in Overweight or obesity (n=89). Visceral Fat Obesity (VFO) vs. Subcutaneous Fat Obesity (SFO) was evaluated on 10-year estimate of cardiovascular disease risk (%) (p=0.007). Visceral fat obesity was associated with significantly higher cardiometabolic risk, including a higher 10-year cardiovascular disease risk estimate (7.09% vs 4.99%) compared to subcutaneous fat obesity in overweight or obese middle-aged women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: